|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Routine Sample Size for a Retest Procedure
Author(s)Jeffrey D. Hofer
This article discusses a straightforward approach that scientists may use to descide how many nonsuspect restest results are required to provide sufficient evidence to overcome an initial suspect result.
Advertisement
Articles in this issue
over 22 years ago
FDA Will Drive Changes for Contract Businessover 22 years ago
In the Spotlight--Decemberover 22 years ago
Novemember 2003over 22 years ago
FDA Seeks Risk-Based Inspection Programover 22 years ago
November 2003over 22 years ago
Clearing Regulatory Hurdlesover 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Women in STEM: Cultivating Scientific Confidence
4
Women in STEM: Inspiration from Innovators in Pharma
5